Kedrion weighs €2bn debt raise to shareholder dividend
Kedrion Biopharma is exploring a debt financing of around €2bn that could be used in part to fund a dividend payment to its shareholders, according to a report by Bloomberg citing unnamed people familiar with the matter.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.